DCP
MEDP icon

Distillate Capital Partners’s Medpace MEDP Stock Holding History

Distillate Capital Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,765
Closed -$15.7M – 131
2026
Q1 		$15.7M Buy
+32,765
New +$16.8M 0.83% 59
2025
Q2 		– Sell
-41,430
Closed -$12.6M – 133
2025
Q1 		$12.6M Sell
41,430
-2,887
-7% -$971K 0.65% 90
2024
Q4 		$14.7M Buy
44,317
+1,155
+3% +$392K 0.72% 94
2024
Q3 		$14.4M Buy
+43,162
New +$16.4M 0.72% 62

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Distillate Capital Partners's MEDP Position: Q2 2026 in Review

Distillate Capital Partners sold out of Medpace (MEDP) in Q2 2026, closing a stake of 32,765 shares — an estimated $15.7M sold.

Distillate Capital Partners first reported a position in MEDP in Q3 2024 and held it in 4 quarters. The position peaked at $15.7M in Q1 2026. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Distillate Capital Partners reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Distillate Capital Partners sold 32,765 Medpace shares in Q2 2026, an estimated $15.7M.
  • Distillate Capital Partners first reported a position in Medpace in Q3 2024 and held it in 4 quarters.
  • Distillate Capital Partners's Medpace position peaked at $15.7M in Q1 2026.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Distillate Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.